Market Overview:
The global intravascular stent market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cardiovascular diseases, technological advancements in intravascular stents, and rising demand for minimally invasive procedures. Based on type, the global intravascular stent market can be segmented into support type and treatment type. The support type segment is further sub-segmented into bare metal stents (BMS), drug-eluting stents (DES), and bioabsorbable scaffold (BAS). The DES segment is expected to grow at a higher CAGR during the forecast period as compared to other segments due to its superior properties such as biocompatibility, anti-thrombotic efficacy, and reduced restenosis rates. Based on application, the global intravascular stent market can be divided into coronary heart disease (CHD), cerebrovascular disease (CVD), great artery disease, and others. CHD accounted for the largest share of this market in 2017 owing to high prevalence of CHD across the globe coupled with increasing adoption of minimally invasive procedures for its treatment.
Product Definition:
An intravascular stent is a device that is inserted into an artery to keep it open. It is often used to treat blockages in the arteries. The stent helps to keep the artery open and allows blood to flow through it more freely.
Support Type:
Support type is a major factor in the growth of the market. The stent market can be segmented into two types on basis of support type which includes self-supporting and scaffold-supported. Support type has an important role to play while designing a stent, as it affects both biocompatibility and clinical performance.
Treatment Type:
Treatment type is used to differentiate between the stents and catheters in the market. It helps in classifying them on the basis of materials, designs, applications and end uses. On the basis of material it can be classified as a drug-eluting stent or bare-metal stent. On the basis of design it can be classified as a straight or coiled wire Stent (SMS).
Application Insights:
Based on application, the global intravascular stent market is segmented into coronary heart disease, cerebrovascular diseases, great artery and others. In 2017, coronary heart disease held the largest share in terms of revenue as well as volume. This is owing to a high prevalence of risk factors such as diabetes mellitus and hyperlipidemia that increase the risk of developing cardiovascular diseases. According to estimates reported by WHO in 2018, over 1 billion people suffer from CVD worldwide which accounts for around 30% of all deaths globally every year.
The cerebrovascular segment is expected to grow at a lucrative rate during the forecast period due to an increasing number of patients suffering from stroke or transient Ischemic Attack (TIA) across various regions including North America and Europe due to rising obesity levels coupled with sedentary lifestyle habits such as lack of physical exercise and high blood pressure levels among other risk factors.
Regional Analysis:
Europe dominated the global market in 2017 owing to high product adoption rate, favorable reimbursement scenario, and presence of key players in the region. In addition, growing target population base with increased risk of developing cardiovascular diseases is expected to drive growth during the forecast period. Asia Pacific is anticipated to witness lucrative growth over the forecast period due to increasing geriatric population base and rising awareness about advanced medical treatments for various disorders including coronary heart disease (CHD). Moreover, improving healthcare infrastructure along with economic development will boost regional market growth. Growing demand for support type intravascular stents from emerging economies such as India & China on account of rapidly expanding medical tourism industry will further fuel regional demand during the forecast period.
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs)
- Rising geriatric population
- Growing demand for minimally invasive procedures
- Technological advancements in intravascular stent devices
- Rising healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Intravascular Stent Market Research Report
By Type
Support Type, Treatment Type
By Application
Coronary Heart Disease, Cerebrovascular, Great Artery, Others
By Companies
Cordis, Boston Scientific, C.R. Bard, Cook Medical, W.L. Gore & Associates, Abbott Laboratories, Medtronic, Terumo, B. Braun Melsungen, Biotronik
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
169
Number of Tables & Figures
119
Customization Available
Yes, the report can be customized as per your need.
Global Intravascular Stent Market Report Segments:
The global Intravascular Stent market is segmented on the basis of:
Types
Support Type, Treatment Type
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Coronary Heart Disease, Cerebrovascular, Great Artery, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cordis
- Boston Scientific
- C.R. Bard
- Cook Medical
- W.L. Gore & Associates
- Abbott Laboratories
- Medtronic
- Terumo
- B. Braun Melsungen
- Biotronik
Highlights of The Intravascular Stent Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Support Type
- Treatment Type
- By Application:
- Coronary Heart Disease
- Cerebrovascular
- Great Artery
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Intravascular Stent Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Intravascular stents are medical devices that are inserted into an artery to keep it open. This can help prevent a heart attack or stroke.
Some of the key players operating in the intravascular stent market are Cordis, Boston Scientific, C.R. Bard, Cook Medical, W.L. Gore & Associates, Abbott Laboratories, Medtronic, Terumo, B. Braun Melsungen, Biotronik.
The intravascular stent market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Intravascular Stent Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Intravascular Stent Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Intravascular Stent Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Intravascular Stent Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Intravascular Stent Market Size & Forecast, 2020-2028
4.5.1 Intravascular Stent Market Size and Y-o-Y Growth
4.5.2 Intravascular Stent Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Support Type
5.2.2 Treatment Type
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Coronary Heart Disease
6.2.2 Cerebrovascular
6.2.3 Great Artery
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Intravascular Stent Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Intravascular Stent Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Support Type
9.6.2 Treatment Type
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Coronary Heart Disease
9.10.2 Cerebrovascular
9.10.3 Great Artery
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Support Type
10.6.2 Treatment Type
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Coronary Heart Disease
10.10.2 Cerebrovascular
10.10.3 Great Artery
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Support Type
11.6.2 Treatment Type
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Coronary Heart Disease
11.10.2 Cerebrovascular
11.10.3 Great Artery
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Support Type
12.6.2 Treatment Type
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Coronary Heart Disease
12.10.2 Cerebrovascular
12.10.3 Great Artery
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Support Type
13.6.2 Treatment Type
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Coronary Heart Disease
13.10.2 Cerebrovascular
13.10.3 Great Artery
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Intravascular Stent Market: Competitive Dashboard
14.2 Global Intravascular Stent Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Cordis
14.3.2 Boston Scientific
14.3.3 C.R. Bard
14.3.4 Cook Medical
14.3.5 W.L. Gore & Associates
14.3.6 Abbott Laboratories
14.3.7 Medtronic
14.3.8 Terumo
14.3.9 B. Braun Melsungen
14.3.10 Biotronik
